TORONTO, Aug. 17, 2021 /CNW/ - Khiron Life Sciences Corp.
("Khiron" or the "Company") (TSXV: KHRN) (OTCQX:
KHRNF)(Frankfurt: A2JMZC), a
vertically integrated medical cannabis leader with core operations
in Latin America and Europe, today announces that it will host a
conference call on Monday, August
23rd , 2021 at 10:00 a.m.
Eastern Time to discuss its results for the second quarter
ended June 30, 2021. The Company will
press release its financial results prior to the conference
call.
Khiron invites individual and institutional investors, as well
as advisors and analysts, to attend the Company's Second Quarter
2021 Conference Call, followed by a Q&A session.
Webcast Details:
DATE: August
23rd, 2021
TIME: 10:00am ET/7:00am PT/4:00pm
CET
PRESENTERS: Alvaro Torres, Khiron
Chief Executive Officer and Director, Joel
Friedman, Khiron Chief Financial Officer, Franziska Katterbach, President Khiron Europe
and Chris Naprawa, Chairman of
Khiron Board of Directors
FORMAT: Live 60 minute presentation & Q&A session
REGISTER LINK:
https://event.on24.com/wcc/r/3368735/FAE8C9703BB105D1B088594F064C2FCD
About Khiron Life Sciences Corp.
Khiron is a leading
vertically integrated medical cannabis company with core operations
in Latin America and Europe. Leveraging wholly-owned medical health
centres and proprietary telemedicine platforms, Khiron combines a
patient-oriented approach, physician education programs, scientific
expertise, product innovation, and agricultural infrastructure to
drive prescriptions and brand loyalty with patients worldwide. The
Company has a sales presence in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in
Mexico in 2021. The Company is led
by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and
diverse executive team and Board of Directors.
Visit Khiron online at investors.khiron.ca and on Instagram
@khironlife.
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment on
analyses, expectations or statements made by third-parties in
respect of Khiron, its securities, or financial or operating
results (as applicable). Although Khiron believes that the
expectations reflected in forward-looking statements in this press
release are reasonable, such forward-looking statement has been
based on expectations, factors and assumptions concerning future
events which may prove to be inaccurate and are subject to numerous
risks and uncertainties, certain of which are beyond Khiron's
control, including the risk factors discussed in Khiron's Annual
Information Form which is available on Khiron's SEDAR profile at
www.sedar.com. The forward-looking information contained in this
press release is expressly qualified by this cautionary statement
and is made as of the date hereof. Khiron disclaims any intention
and has no obligation or responsibility, except as required by law,
to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
Neither the TSXV nor its Regulation Services Provider (as that
term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this press release.
Investor Contact:
Paola Ricardo
E: investors@khiron.ca
T: +1 (647) 556-5750
Media Contact:
Elsa
Navarro
Vice President, Communications
E: enavarro@khiron.ca
Khiron Europe:
Franziska Katterbach, President
E: fkatterbach@khiron.ca
View original content to download
multimedia:https://www.prnewswire.com/news-releases/khiron-to-host-second-quarter-2021-conference-call-on-august-23-2021-301356422.html
SOURCE Khiron Life Sciences Corp.